Evaluation of Dental Plaque Removal Efficacy of Oral Care Products

Dental plaque is the primary etiological factor in caries, gingivitis, and periodontal disease, which makes proven plaque removal efficacy the core performance claim for toothbrushes, toothpastes, mouthrinses, and interdental cleaners. This article explains how accredited third-party laboratories assess plaque removal performance through standardized in vitro biofilm models, simulated brushing tests, abrasivity evaluation, and controlled clinical trials aligned with ISO, ASTM, and GB standards.

Technical Overview

Dental plaque is a structurally organized biofilm that forms on tooth surfaces through the adsorption of a salivary pellicle followed by sequential bacterial colonization. Key planktonic and sessile species include Streptococcus mutans, Streptococcus sanguinis, Actinomyces naeslundii, Fusobacterium nucleatum, and Porphyromonas gingivalis. If not regularly and effectively disrupted, the mature biofilm produces acid challenges that demineralize enamel and triggers inflammatory host responses in the gingival tissues.

Because plaque removal is a measurable and comparable performance attribute, manufacturers of oral care products must substantiate related efficacy claims with objective scientific evidence. Regulatory and market frameworks, such as the EU Cosmetics Regulation (EC) No 1223/2009 together with the Common Criteria Regulation (EU) No 655/2013, professional acceptance programs, and national toothpaste and toothbrush supervision requirements, all require that claims such as "removes plaque," "reduces plaque regrowth," or "clinically proven" be supported by robust test data generated under controlled conditions.

Evaluation of plaque removal therefore follows a tiered evidence model: laboratory screening using artificial plaque and in vitro biofilm models, mechanical and safety testing of cleaning devices and formulations, and, where comparative or superiority claims are intended, controlled clinical studies using validated plaque indices and examiner blinding.

Testing Samples

Manual Toothbrushes

Adult and pediatric manual toothbrushes with filament configurations such as flat-trim, angled, multi-level, or tapered-end bristles. Evaluations cover filament tip geometry, tuft density, end-rounding quality, and cleaning performance under standardized brushing parameters.

Powered Toothbrushes and Replacement Brush Heads

Rotating-oscillating, sonic, and ultrasonic devices, assessed for stroke dynamics, force delivery, and plaque removal efficiency on flat surfaces, interproximal spaces, and gingival margins under laboratory simulation and clinical conditions.

Toothpastes and Dentifrice Formats

Conventional, anti-cavity, anti-sensitivity, whitening, and herbal dentifrices, including paste, gel, powder, and tablet formats. Formulations are evaluated for cleaning efficacy, abrasivity, and compatibility with plaque removal mechanics.

Mouthrinses and Oral Sprays

Antiseptic and cosmetic oral rinses containing active agents such as chlorhexidine digluconate, cetylpyridinium chloride, essential oils, or zinc compounds, assessed for anti-plaque and anti-regrowth activity and, where applicable, substantiation of antigingivitis performance.

Interdental Cleaners

Dental floss, tape, interdental brushes, and oral irrigators, evaluated for interproximal plaque disruption relative to brushing alone.

Testing Items

Depending on the product category and intended marketing claims, a typical plaque removal evaluation program includes the following test items:

• Plaque removal efficacy: quantified as the percentage of biofilm or artificial plaque removed after a standardized treatment or brushing cycle.
• Plaque regrowth inhibition: residual anti-plaque effect measured over multi-day biofilm growth or in longer clinical observation windows.
• Antimicrobial activity: bacteriostatic and bactericidal performance against plaque-forming organisms such as Streptococcus mutans and Actinomyces naeslundii, expressed as inhibition zones, minimum inhibitory concentration (MIC), or microbial reduction rates.
• Biofilm biomass and viability: crystal violet staining, viable colony counting (CFU), and fluorescence-based live/dead assessment to quantify remaining biofilm mass and metabolic activity.
• Cleaning coverage: removal performance in anatomically challenging zones, including interproximal contacts, the gingival margin, and posterior lingual surfaces.
• Abrasive safety profile: relative dentine abrasivity (RDA) and relative enamel abrasivity (REA), plus profilometric surface loss measurement to confirm that cleaning performance does not compromise hard tissues.
• Comparative performance: side-by-side benchmarking against a reference product or competitor to substantiate "up to X% more plaque removed" style claims.

Testing Methods

In Vitro Biofilm Model

Single-species or multi-species biofilms are cultivated on saliva-coated hydroxyapatite discs or polished bovine enamel specimens under anaerobic or microaerophilic conditions to simulate supragingival plaque. After a defined maturation period, specimens are exposed to the test product, product dilutions, or a brushing protocol. Remaining biofilm is quantified by optical density of solubilized crystal violet stain, CFU enumeration after sonication and plating, or confocal laser scanning microscopy with fluorescence viability probes. Results are reported as percentage biomass or viability reduction relative to negative and positive controls.

Simulated Brushing and Artificial Plaque Testing

Brushing simulation apparatus, consistent with the principles of ISO 14569-1 for wear by toothbrushing, applies controlled load, stroke frequency, stroke count, and dentifrice slurry concentration to specimens coated with a standardized artificial plaque substrate or stained biofilm. Residual plaque is disclosed with erythrosine or two-tone disclosing agents and quantified through calibrated digital imaging and planimetric analysis, yielding an objective percentage removal value for each brush or formulation configuration.

Abrasivity Assessment

To ensure cleaning benefits are delivered within a safe abrasive window, relative dentine abrasivity is determined in accordance with ISO 22254, with calcium pyrophosphate used as the reference material. Enamel and dentine wear can be further characterized by contact profilometry to measure surface loss and surface roughness changes after extended brushing cycles, verifying compliance with the abrasivity limits referenced in ISO 11609 for toothpastes.

Clinical Efficacy Trials

Where product-labeling claims require human evidence, controlled clinical studies are conducted under ethics approval and in accordance with the Declaration of Helsinki. Common designs include randomized, examiner-blinded, single-brushing crossover studies and four- to eight-week unsupervised home-use parallel studies. Plaque levels are scored using validated indices:

• Turesky modification of the Quigley-Hein index (TQHI) for whole-mouth and site-specific plaque scoring.
• Silness-Loe plaque index for thickness and extension of plaque at the gingival margin.
• Rustogi Modified Navy Plaque Index for zone-specific analysis in toothbrush trials.

Disclosed plaque is scored by calibrated blinded examiners and, increasingly, captured with standardized repositioning photography for digital image analysis. Sample sizes typically range from approximately twenty to thirty subjects for crossover single-use studies to sixty or more per arm for long-term parallel designs, powered to detect the target effect size at a significance level of 0.05.

Data Analysis and Claim Substantiation

Quantitative results are analyzed using appropriate statistical methods, including paired t-tests, analysis of variance, or non-parametric equivalents, with adjustment for crossover carryover where applicable. Outcomes are translated into defensible claims, such as statistically significant reductions in plaque index scores, percentage improvements versus baseline, or non-inferiority or superiority conclusions versus a benchmark reference product, with all data retained in a technical dossier for regulatory and advertising review.

Applications

Plaque removal evaluation data support the full product lifecycle in the oral care industry:

• Research and development: screening bristle geometries, abrasive systems, and antimicrobial actives during formulation and design iteration.
• Claim substantiation: generating the evidence file required for marketing statements under advertising laws and cosmetic claim regulations in target markets.
• Regulatory compliance and acceptance programs: supporting product registration, standards conformity for toothpastes and toothbrushes under frameworks such as ISO 11609 and ISO 20126, and applications to professional dental acceptance schemes.
• Quality control: verifying that production batches of brush heads and dentifrice formulations remain consistent with the validated performance profile.
• Competitive benchmarking: objectively demonstrating performance advantages over reference or competitor products in procurement and retail channel presentations.

FAQ

Which standards are most relevant to plaque removal evaluation?

Core references include ISO 11609 for toothpastes, ISO 20126 for manual toothbrushes, ISO 20127 for powered toothbrushes, ISO 16409 for oral rinses, ISO 22254 for relative dentine abrasivity, and ISO 14569-1 for brushing-based wear simulation. Clinical plaque indices such as the Turesky modification of the Quigley-Hein index provide the validated endpoints for human studies.

Is a clinical trial always required to support a plaque removal claim?

Not necessarily. General cleaning performance can often be substantiated with standardized in vitro biofilm or artificial plaque removal data. However, comparative claims, "clinically proven" statements, and claims linked to gingival health outcomes generally require controlled clinical studies with validated indices and blinded examiners.

How is plaque removal performance quantified?

Laboratory results are reported as percentage reduction in biofilm biomass, viability, or stained plaque area relative to controls. Clinical results are reported as changes in plaque index scores from baseline, percentage plaque coverage by digital image analysis, and the proportion of subjects achieving defined improvement thresholds.

How does abrasivity relate to plaque removal testing?

Abrasivity determines how much cleaning is achieved through mechanical substrate removal. Since excessive abrasion can damage dentine and enamel, RDA and REA testing is run alongside cleaning tests to confirm that the product delivers effective plaque removal within a safe abrasive range, consistent with the limits recognized in international toothpaste standards.

How many samples are needed and what is a typical project timeline?

Laboratory biofilm and brushing studies generally require batches of finished products or components such as several dozen brush heads and standard production units of dentifrice, with completion typically within four to eight weeks. Clinical trials, including ethics approval, enrollment, and examination visits, usually require three to six months depending on design and sample size.

Can natural, herbal, or fluoride-free formulations be evaluated with the same methods?

Yes. The in vitro biofilm, artificial plaque, and clinical index methodologies are formulation-agnostic and can objectively quantify the plaque removal and anti-regrowth performance of herbal, enzyme-based, and fluoride-free products, provided appropriate positive and negative controls are included.